Cumulus Neuroscience

📍 Belfast, United Kingdom🗓 Founded 2015👥 33 employees💰 Last funded Dec 2023
Biotechnology Research🌐 cumulusneuro.com
Website LinkedIn
We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
United Kingdom
1
Frequently asked questions
Who invested in Cumulus Neuroscience?
Cumulus Neuroscience has 2 investors on record on gritt.io and 2 late-stage investors.
When did Cumulus Neuroscience last raise funding?
The most recent investment in Cumulus Neuroscience recorded on gritt.io was in December 2023.
When was Cumulus Neuroscience founded?
Cumulus Neuroscience was founded in 2015.
What industry is Cumulus Neuroscience in?
Cumulus Neuroscience operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Cumulus Neuroscience based?
Cumulus Neuroscience is headquartered in Belfast, United Kingdom.